References
- Tefferi A, Pruthi RK. The biochemical basis of cobalamin deficiency. Mayo Clin Proc 1994;69(2):181–6. doi: 10.1016/S0025-6196(12)61046-5
- Allen RH, Stabler SP, Savage DG, Lindenbaum J. Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. FASEB J 1993;7(14):1344–53.
- Scalabrino G, Veber D, Mutti E. New pathogenesis of the cobalamin-deficient neuropathy. Med Secoli 2007;19(1):9–18.
- Scalabrino G, Peracchi M. New insights into the pathophysiology of cobalamin deficiency. Trends Mol Med 2006;12(6):247–54. doi: 10.1016/j.molmed.2006.04.008
- Antony AC. Megaloblastic anemias. In: Hoffman R, Benz E, Silberstein L, Heslop H, Weitz J, Anastasi J, (eds.) Hematology basic principles and practice, 6th ed. Canada: Elsevier Saunders; 2013. pp. 473–504.
- Jakubowski H. Pathophysiological consequences of homocysteine excess. J Nutr 2006;136(6 Suppl):1741S–9S.
- Yilmaz N. Relationship between paraoxonase and homocysteine: crossroads of oxidative diseases. Arch Med Sci 2012;8(1):138–53. doi: 10.5114/aoms.2012.27294
- Suszynska J, Tisonczyk J, Lee HG, Smith MA, Jakubowski H. Reduced homocysteine-thiolactonase activity in Alzheimer's disease. J Alzheimers Dis 2010;19:1177.
- Jakubowski H. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J Physiol Pharmacol 2008;59(Suppl. 9):155–67.
- Blatter MC, James RW, Messmer S, Barja F, Pometta D. Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45: identity of K-45 with paraoxonase. Eur J Biochem 1993;211:871–9. doi: 10.1111/j.1432-1033.1993.tb17620.x
- Mackness B, Durrington PN, Mackness MI. Human serum paraoxonase. Gen Pharmacol 1998;31:329–36. doi: 10.1016/S0306-3623(98)00028-7
- Canales A, Sanchez-Muniz FJ. Paraoxonase, something more than an enyzme? Med Clin (Barc) 2003;121:537–48. doi: 10.1016/S0025-7753(03)74011-1
- Jakubowski H. Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease. J Biol Chem 2002;277:30425–8. doi: 10.1074/jbc.C200267200
- Perla-Kaján J, Jakubowski H. Paraoxonase 1 protects against protein N-homocysteinylation in humans. FASEB J 2010;24(3):931–6. doi: 10.1096/fj.09-144410
- Perla-Kaján J, Jakubowski H. Paraoxonase 1 and homocysteine metabolism. Amino Acids 2012;43(4):1405–17. doi: 10.1007/s00726-012-1321-z
- Koç A, Cengiz M, Ozdemir ZC, Celik H. Paraoxonase and arylesterase activities in children with iron deficiency anemia and vitamin B12 deficiency anemia. Pediatr Hematol Oncol 2012;29(4):345–53. doi: 10.3109/08880018.2011.645185
- Karikas GA, Kriebardis A, Samara I, Papachristodoulou M, Fytou-Pallikari A. Serum homocysteine levels and paraoxonase 1 activity in preschool aged children in Greece. Clin Chem Lab Med 2006;44:623–7. doi: 10.1515/CCLM.2006.110
- Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, Schmitt D. Relationship of paraoxonase 1 (PON1) gene polymorphism and functional activity with systemic oxidative stress and cardiovascular risk. JAMA 2008;299:1265–76. doi: 10.1001/jama.299.11.1265